Ir para conteúdo

Cuidados Intensivos

Gestão e Reversão da Anticoagulação

Reversal of antithrombotic agents. (abre uma nova janela)

Bauer KA.

Fonte‎: Am J Hematol 2012;87 Suppl 1:S119-26.

Indexado‎: PubMed 22460529

DOI‎: 10.1002/ajh.23165

https://www.ncbi.nlm.nih.gov/pubmed/22460529 (abre uma nova janela)

Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (abre uma nova janela)

Chai-Adisaksopha C, Hillis C, Lim W, Boonyawat K, Moffat K, Crowther M

Fonte‎: J Thromb Haemost 2015;13(10):1790-8.

Indexado‎: PubMed 26270886

DOI‎: 10.1111/jth.13117

https://www.ncbi.nlm.nih.gov/pubmed/26270886 (abre uma nova janela)

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (abre uma nova janela)

Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, Yue P, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Demchuk AM, Pallin DJ, Concha M, Goodman S, Leeds J, Souza S, Siegal DM, Zotova E, Meeks B, Ahmad S, Nakamya J, Milling TJ Jr; ANNEXA-4 Investigators

Fonte‎: N Engl J Med 2019;380(14):1326-35.

Indexado‎: PubMed 30730782

DOI‎: 10.1056/NEJMoa1814051

https://www.ncbi.nlm.nih.gov/pubmed/30730782 (abre uma nova janela)

Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (abre uma nova janela)

Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M; ANNEXA-4 Investigators

Fonte‎: N Engl J Med 2016;375(12):1131-41.

Indexado‎: PubMed 27573206

DOI‎: 10.1056/NEJMoa1607887

https://www.ncbi.nlm.nih.gov/pubmed/27573206 (abre uma nova janela)

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (abre uma nova janela)

Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M

Fonte‎: Circulation 2011;124(14):1573-9.

Indexado‎: PubMed 21900088

DOI‎: 10.1161/CIRCULATIONAHA.111.029017

https://www.ncbi.nlm.nih.gov/pubmed/21900088 (abre uma nova janela)

Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (abre uma nova janela)

Gordon JL, Fabian TC, Lee MD, Dugdale M

Fonte‎: J Trauma Acute Care Surg 2013;75(3):475-86.

Indexado‎: PubMed 24089118

DOI‎: 10.1097/TA.0b013e3182a07391

https://www.ncbi.nlm.nih.gov/pubmed/24089118 (abre uma nova janela)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (abre uma nova janela)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

Fonte‎: Am J Hematol 2012;87 Suppl 1:S141-5.

Indexado‎: PubMed 22473649

DOI‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (abre uma nova janela)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (abre uma nova janela)

Levi M, Eerenberg E, Kamphuisen PW.

Fonte‎: J Thromb Haemost 2011;9(9):1705-12.

Indexado‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (abre uma nova janela)

Emergency reversal of warfarin anticoagulation. (abre uma nova janela)

Lin Y, Callum J.

Fonte‎: CMAJ 2010;182(18):2004.

Indexado‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (abre uma nova janela)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (abre uma nova janela)

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

Fonte‎: Thromb Haemost 2012;108(2):217-24.

Indexado‎: PubMed 22627883

DOI‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 (abre uma nova janela)

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (abre uma nova janela)

Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group.

Fonte‎: J Thromb Haemost 2008;6(4):622-31.

Indexado‎: PubMed 18208533

DOI‎: 10.1111/j.1538-7836.2008.02904.x

https://www.ncbi.nlm.nih.gov/pubmed/18208533 (abre uma nova janela)

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (abre uma nova janela)

Piran S, Khatib R, Schulman S, Majeed A, Holbrook A, Witt DM, Wiercioch W, Schünemann HJ, Nieuwlaat R

Fonte‎: Blood Adv 2019;3(2):158-67.

Indexado‎: PubMed 30658963

DOI‎: 10.1182/bloodadvances.2018024133

https://www.ncbi.nlm.nih.gov/pubmed/30658963 (abre uma nova janela)

Idarucizumab for dabigatran reversal. (abre uma nova janela)

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

Fonte‎: N Engl J Med 2015;373(6):511-20.

Indexado‎: PubMed 26095746

DOI‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 (abre uma nova janela)

Idarucizumab for dabigatran reversal - full cohort analysis. (abre uma nova janela)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Fonte‎: N Engl J Med 2017;377(5):431-41.

Indexado‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (abre uma nova janela)

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (abre uma nova janela)

Reiter RA, Mayr F, Blazicek H, Galehr E, Jilma-Stohlawetz P, Domanovits H, Jilma B

Fonte‎: Blood 2003;102(13):4594-9.

Indexado‎: PubMed 12920042

DOI‎: 10.1182/blood-2002-11-3566

https://www.ncbi.nlm.nih.gov/pubmed/12920042 (abre uma nova janela)

Role of agents for reversing the effects of target-specific oral anticoagulants. (abre uma nova janela)

Riley TR, Gauthier-Lewis ML, Sanchez CK, Douglas JS

Fonte‎: Am J Health Syst Pharm 2017;74(2):54-61.

Indexado‎: PubMed 27895055

DOI‎: 10.2146/ajhp150810

https://www.ncbi.nlm.nih.gov/pubmed/27895055 (abre uma nova janela)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (abre uma nova janela)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Fonte‎: Anesth Analg 2011;113(4):703-10.

Indexado‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (abre uma nova janela)

2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (abre uma nova janela)

Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Messé SR, Pollack CV Jr, Rodriguez F, Sarode R, Siegal D, Wiggins BS

Fonte‎: J Am Coll Cardiol 2017;70(24):3042-67.

Indexado‎: PubMed 29203195

DOI‎: 10.1016/j.jacc.2017.09.1085

https://www.ncbi.nlm.nih.gov/pubmed/29203195 (abre uma nova janela)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (abre uma nova janela)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Fonte‎: World Neurosurg 2014;81(1):110-5.

Indexado‎: PubMed 23220122

DOI‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (abre uma nova janela)

Reversal of warfarin-induced hemorrhage in the emergency department. (abre uma nova janela)

Zareh M, Davis A, Henderson S.

Fonte‎: West J Emerg Med 2011;12(4):386-92.

Indexado‎: PubMed 22224125

DOI‎: 10.5811/westjem.2011.3.2051

https://www.ncbi.nlm.nih.gov/pubmed/22224125 (abre uma nova janela)